Genedrive moves to cash position as bondholder converts loan
Following completion, Genedrive will have gross cash balances of £8.6mln and debt of £2.6mln
Company
genedrive PLC
LON:GDR
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
240 stories · page 4 of 12
Genedrive makes life easier for coronavirus testing labs
The diagnostics firm has been rocketing thanks to its efficient coronavirus tests, but it is also focusing on a baby deafness assay
Coronavirus pandemic gives AIM's healthcare sector a new outlook
Healthcare firms have raised £390mln in the four months to April
Archive
Small Cap Wrap- Tissue Regenix; genedrive: Tekcapital and more...
Breakfast Buffet Synectics 120p £21.3m (SNX.) Two new multi-year contracts with existing long-term customers.
Genedrive coronavirus test capable of generating £1.5mln of revenue per week, says broker
The molecular diagnostics company's new test can support high-volume coronavirus testing for governments
Proactive news headlines: Genedrive, OPG Power Ventures, Tiziana Life Sciences, One Media IP ...
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive's shares surge as coronavirus (COVID-19) testing kit gets CE-IVD mark
Now that CE-IVD marking has been achieved, the company can start across the EU - including the UK - immediately
Resource and travel sectors wield the biggest blades as companies slash capital expenditure
A total of £10.4bn has been slashed from planned capex in the energy sector, with all but £1.4bn of that coming from Shell and BP
UK in talks to buy Roche’s Covid-19 antibody tests following US, EU lead
Roche said it has capacity to deliver hundreds of thousands of the tests per week to the UK
genedrive raises £1mln in oversubscribed broker option to placing
The broker option forms part of the fundraising announced last week to support the rapid development of the company's coronavirus tests
genedrive hepatitis-C diagnostic joins list of WHO pre-qualified devices; launches £8mln fund-raising
The move means the product joins a list of devices eligible for purchase by United Nations procurement agencies, with World Health Organisation member states encouraged to buy from the list
Archive
Proactive news headlines: Genedrive, i3 Energy, Tekcapital, Vectura Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive surges as coronavirus test kit passes critical development milestones
The diagnostics firm is now aiming for the test to receive CE marking in around three weeks
Genedrive and Inspiration Healthcare to distribute neonatal hearing loss test in UK & Ireland
The Genedrive test screens newborns for a genetic mutation called mt-RNR1 that can cause lifelong and irreversible deafness to a child upon administration of certain antibiotics
Archive
Proactive news snapshot: Genedrive, Feedback, Power Metal Resources, Gfinity, Tissue Regenix…
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive shares jump as it aims to have a coronavirus test available within five weeks
Genedrive and Cytiva (formerly GE Healthcare Life Science) will jointly develop the Genedrive 96 SARS-CoV-2 assay for use on lab-based PCR instruments.
Genedrive CEO targets ‘fastest route to market’ for out-of-hospital coronavirus test
The company's test for coronavirus is designed to deliver a result quickly in close proximity to patients, rather than needing to send samples to labs for a conclusive result
Firms across the coronavirus treatment chain see share prices surge
Companies involved in diagnostics, drug development and medical equipment provision have all seen strong stock price rises as the world grapples with the pandemic
Archive
Proactive news snapshot: Genedrive, Silence Therapeutics, Gfinity, SIMEC Atlantis Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Bagir shabbier as coronavirus forces factory closures
A look at some of the major risers and fallers in London on Wednesday